연구물
7건 검색
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1KCI Q2Pegfilgrastim Prophylaxis Is Effective in the Prevention of Febrile Neutropenia and Reduces Mortality in Patients Aged >= 75 Years with Diffuse Large B-Cell Lymphoma Treated with R-CHOP: A Prospective Cohort Study
정성현김석진윤덕현박용강혜진신호진외 25명
- 연구출판물 · 학술지 논문JCR Q1Scopus Q2A randomized, multicenter, phase II/III study to determine the optimal dose and to evaluate the efficacy and safety of pegteograstim (GCPGC) on chemotherapy-induced neutropenia compared to pegfilgrastim in breast cancer patients: KCSG PC10-09
Lee, Ki HyeongKim, Ji-YeonLee, Moon HeeHan, Hye SookLim, Joo Han최영진외 12명
- 연구출판물 · 학술지 논문JCR Q1Scopus Q1An observational, prospective, open label, multicenter study to evaluate the safety and effectiveness of pegfilgrastim as secondary prophylaxis to decrease the incidence of febrile neutropenia in Korean female patients with breast cancer
- 연구출판물 · 학술지 논문JCR Q2Scopus Q1KCI Q2Predictive Parameters of Febrile Neutropenia and Clinical Significance of G-CSF Receptor Signaling Pathway in the Development of Neutropenia during R-CHOP Chemotherapy with Prophylactic Pegfilgrastim in Patients with Diffuse Large B-Cell Lymphoma
- 연구출판물 · 학술지 논문JCR Q3Scopus Q2Comparison of prophylactic effects for chemotherapy induced neutropenia between same-day versus next-day administration of pegteograstim (Neurapeg (R)) in patients treated with chemotherapy regimen composed of day 1 intensive myleosuppressive agent: A randomized phase III clinical trial
Comparison of prophylactic effects for chemotherapy induced neutropenia between same-day versus next-day administration of pegteograstim (Neurapeg®) in patients treated with chemotherapy regimen composed of day 1 intensive myleosuppressive agent: A randomized phase III clinical trial
- 연구출판물 · 학술지 논문JCR Q4Scopus Q3Phase II study of neoadjuvant chemotherapy with four cycles of dose-dense MVAC followed by radical cystectomy in Korean patients with muscle-invasive or locally advanced urothelial carcinoma of bladder
- 연구출판물 · 학술지 논문JCR Q4Scopus Q2Underutilisation of prophylactic G-CSF in breast cancer patients receiving adjuvant docetaxel/cyclophosphamide chemotherapy



로그인
홈
Researcher Page
ORCID
ISNI